3.80
                                            Schlusskurs vom Vortag:
              $3.79
            Offen:
              $3.74
            24-Stunden-Volumen:
                177.31K
            Relative Volume:
              0.96
            Marktkapitalisierung:
                $20.57M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-21.21M
            KGV:
              -0.1166
            EPS:
                -32.6
            Netto-Cashflow:
                $-16.86M
            1W Leistung:
              +1.06%
            1M Leistung:
              -9.09%
            6M Leistung:
                -12.04%
            1J Leistung:
              -1.30%
            Cingulate Inc Stock (CING) Company Profile
Firmenname
                  
                      Cingulate Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (913) 942-2300
                    
                Adresse
                  
                      1901 W. 47TH PLACE, KANSAS CITY
                    
                Vergleichen Sie CING mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CING
                            
                             
                        Cingulate Inc 
                           | 
                    3.80 | 21.25M | 0 | -21.21M | -16.86M | -32.60 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Cingulate Inc Stock (CING) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-01-10 | Eingeleitet | ROTH MKM | Buy | 
| 2023-12-22 | Herabstufung | Laidlaw | Buy → Hold | 
Cingulate Inc Aktie (CING) Neueste Nachrichten
Trend analysis for Cingulate Inc. Equity Warrant this weekBond Market & Long-Term Safe Investment Plans - newser.com
What data driven models say about Cingulate Inc.’s futureJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Signal strength of Cingulate Inc. stock in tech scannersJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Will Cingulate Inc. Equity Warrant stock recover faster than market2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
Will Cingulate Inc. Equity Warrant stock deliver long term returns2025 AllTime Highs & Intraday High Probability Alerts - newser.com
Combining price and volume data for Cingulate Inc.Weekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Cingulate Inc. stock ready for a breakoutWeekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
Can Cingulate Inc. stock deliver consistent earnings growthWeekly Trend Recap & Community Trade Idea Sharing Platform - newser.com
Why Cingulate Inc. stock remains on watchlists2025 Price Targets & Low Risk Entry Point Tips - newser.com
Will Cingulate Inc. Equity Warrant stock pay special dividendsWeekly Profit Report & Growth Focused Entry Reports - newser.com
Is Cingulate Inc. Equity Warrant meeting your algorithmic filter criteriaBreakout Watch & Verified Technical Trade Signals - newser.com
Measuring Cingulate Inc. Equity Warrant’s beta against major indices2025 Technical Overview & Fast Momentum Stock Entry Tips - newser.com
Why Cingulate Inc. stock is seen as undervaluedGold Moves & Low Risk High Reward Trade Ideas - newser.com
Will Cingulate Inc. stock beat EPS estimates2025 Earnings Surprises & High Return Stock Watch Alerts - newser.com
Why Cingulate Inc. Equity Warrant stock appeals to analystsJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com
Can technical indicators confirm Cingulate Inc. Equity Warrant’s reversal2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Can Cingulate Inc. Equity Warrant stock deliver consistent earnings growthWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Will Cingulate Inc. stock remain a Wall Street favorite2025 Top Gainers & Smart Swing Trading Techniques - newser.com
Will a bounce in Cingulate Inc. offer an exit2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Can Cingulate Inc. Equity Warrant stock continue upward trendPortfolio Gains Summary & Fast Exit Strategy with Risk Control - newser.com
How supply chain issues affect Cingulate Inc. stockMarket Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Cingulate Inc. (CING) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is Cingulate Inc. Equity Warrant stock supported by strong cash flowsQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com
How Cingulate Inc. Equity Warrant stock trades during market volatilityWeekly Gains Summary & Long Hold Capital Preservation Plans - newser.com
Real time breakdown of Cingulate Inc. stock performanceMarket Risk Summary & Momentum Based Trading Ideas - newser.com
Operating cash flow per share of Cingulate, Inc. Warrant 2021-03.12.26 on Cingulate – NASDAQ:CINGW - TradingView
Can Cingulate Inc. stock resist market sell offsInsider Buying & Breakout Confirmation Trade Signals - newser.com
Risk adjusted return profile for Cingulate Inc. Equity Warrant analyzedJuly 2025 Levels & Risk Managed Investment Signals - newser.com
Finanzdaten der Cingulate Inc-Aktie (CING)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):